← All Investors
LIXTE BIOTECHNOLOGY HLDGS IN
LIXTW
Holders
0
Combined Value
$0
Combined Shares
0
Current Price
$0.02
52W High
$0.38
vs 52W High
−94.2%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q3 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$722 | ~$0.03 |
| Q2 2025 | Ken Griffin - Citadel Advisors | SELL | −$22 | ~$0.03 |
| Q1 2025 | Ken Griffin - Citadel Advisors | SELL | −$43 | ~$0.03 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SELL | −$23 | ~$0.03 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SELL | −$206 | ~$0.05 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$2.0K | ~$0.06 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q2 2025 | 1 | 25,231 | −3.1% | $722 | $0.03 |
| Q1 2025 | 1 | 26,032 | −4.8% | $880 | $0.03 |
| Q4 2024 | 1 | 27,332 | −2.9% | $793 | $0.03 |
| Q3 2024 | 1 | 28,141 | −12.4% | $1.5K | $0.05 |
| Q2 2024 | 1 | 32,122 | — | $2.0K | $0.06 |